March 20, 2024 · Form 4 insider transaction
Umstead John W. V bought 37,500 shares of G1 Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.; Each RSU represents a contingent right to receive one share of Issuer common stock.; Represents (i) 9,421 shares of common stock; (ii) 425 RSUs from award granted on January 4, 2021; (iii) 2,000 RSUs from award granted on January 3, 2022; (iv) 2,250 RSUs from award granted on January 3, 2023; (v) 37,500 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; (vii) 37,300 RSU's granted on January 3, 2024; and (viii) 37,500 RSU's from award granted on March 20, 2024.